BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,172 | +0.4% | 578,344 | -1.7% | 0.09% | +7.3% |
| Q2 2023 | $50,983 | -14.3% | 588,170 | -3.9% | 0.08% | -20.4% |
| Q1 2023 | $59,485 | -24.0% | 611,736 | -19.1% | 0.10% | -34.4% |
| Q4 2022 | $78,239 | -99.9% | 756,006 | -6.8% | 0.16% | +12.9% |
| Q3 2022 | $68,748,000 | +0.8% | 810,991 | -1.4% | 0.14% | +9.4% |
| Q2 2022 | $68,184,000 | -1.9% | 822,783 | -8.7% | 0.13% | +36.6% |
| Q1 2022 | $69,512,000 | -13.1% | 901,591 | -0.4% | 0.09% | -4.1% |
| Q4 2021 | $80,014,000 | +30.2% | 905,641 | +13.9% | 0.10% | +27.6% |
| Q3 2021 | $61,450,000 | -3.8% | 795,069 | +3.9% | 0.08% | -1.3% |
| Q2 2021 | $63,851,000 | +24.7% | 765,231 | +12.9% | 0.08% | +16.7% |
| Q1 2021 | $51,201,000 | -7.9% | 678,080 | +7.0% | 0.07% | -9.6% |
| Q4 2020 | $55,568,000 | +18.1% | 633,683 | +2.4% | 0.07% | +7.4% |
| Q3 2020 | $47,060,000 | -60.2% | 618,555 | -35.5% | 0.07% | -64.2% |
| Q2 2020 | $118,256,000 | -3.1% | 958,774 | -33.6% | 0.19% | -24.3% |
| Q1 2020 | $122,036,000 | -7.3% | 1,444,217 | -7.3% | 0.25% | +12.1% |
| Q4 2019 | $131,688,000 | +102.9% | 1,557,517 | +61.8% | 0.22% | +79.2% |
| Q3 2019 | $64,887,000 | -46.8% | 962,720 | +2.1% | 0.12% | -45.2% |
| Q2 2019 | $122,039,000 | +4.6% | 942,949 | +3.1% | 0.23% | -0.4% |
| Q1 2019 | $116,669,000 | +52.4% | 914,673 | +1.8% | 0.23% | +26.5% |
| Q4 2018 | $76,542,000 | -36.5% | 898,912 | -0.9% | 0.18% | -23.3% |
| Q3 2018 | $120,544,000 | +4.0% | 907,254 | -1.4% | 0.24% | +0.9% |
| Q2 2018 | $115,932,000 | +29.3% | 920,529 | +20.2% | 0.23% | +23.2% |
| Q1 2018 | $89,661,000 | +27.7% | 766,113 | +35.6% | 0.19% | +30.1% |
| Q4 2017 | $70,193,000 | +57.5% | 565,150 | +60.2% | 0.15% | +50.5% |
| Q3 2017 | $44,554,000 | – | 352,748 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |